Highlights Vertex Pharmaceuticals Incorporated

Equities

VRTX

US92532F1003

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-07 pm EDT			5-day change	1st Jan Change
483 ^USD	-0.51%		+6.08%	+18.72%

Jun. 07	Vertex Pharmaceuticals Says Phase 3 Data Show Trikafta Improves Lung Function in Cystic Fibrosis Patients	MT
Jun. 05	Vertex Pharmaceuticals Insider Sold Shares Worth $1,495,000, According to a Recent SEC Filing	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Vertex Pharmaceuticals Says Phase 3 Data Show Trikafta Improves Lung Function in Cystic Fibrosis Patients	Jun. 07	MT
ADDvise Group’s Axelerist Bags $1.4 Million Order for Medical, Lab Equipment	May. 21	MT
Vertex Pharmaceuticals Incorporated completed the acquisition of Alpine Immune Sciences, Inc. from a group of shareholders.	May. 19	CI
Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone	May. 10	MT
Vertex Pharmaceuticals Q1 Non-GAAP EPS, Revenue Increase	May. 06	MT
Vertex Pharmaceuticals 1Q Sales Up 13% on Cystic Fibrosis Drug	May. 06	DJ
Earnings Flash (VRTX) VERTEX PHARMACEUTICALS INCORPORATED Reports Q1 EPS $4.76, vs. Street Est of $4.06	May. 06	MT
Vertex Pharmaceuticals Reiterates FY 2024 Total Product Revenue Guidance of $10.55-$10.75 Billion	May. 06	MT
Vertex Pharmaceuticals Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 06	CI
Vertex tops Q1 profit estimates on robust demand for cystic fibrosis treatments	May. 06	RE
Vertex Pharmaceuticals Incorporated Re-Iterates Earnings Guidance for the Full Year 2024	May. 06	CI
Equity Markets Higher as Traders Parse Fed Official's Remarks	May. 06	MT
Futures Rise Pre-Bell Ahead of Latest Earnings Week; Asia Mostly Up, Europe Strong	May. 06	MT
S&P 500 Posts Weekly Gain as Weaker-Than-Expected April Jobs Report Boosts Hopes for FOMC Rate Cut	May. 03	MT
Vertex Pharmaceuticals Announces European Commission Approval for KALYDECO to Treat Infants with Cystic Fibrosis Ages 1 Month and Older	Apr. 26	CI
Vertex Pharmaceuticals Says FDA Granted Rolling Review of Suzetrigine to Treat Acute Pain	Apr. 18	MT
Health Care Slips on Risk Bias -- Health Care Roundup	Apr. 11	DJ
Global markets live: Airbus, UBS, KKR, Meta Platforms, Tesla...	Apr. 11
Sector Update: Health Care Stocks Steady Pre-Bell Thursday	Apr. 11	MT
Sector Update: Health Care	Apr. 11	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Vertex Pharmaceuticals Incorporated : Vertex and Crispr to market $2.2 million treatment for sickle cell disease

December 11, 2023 at 05:47 am EST